Introduction Many of us reach a point in our wellness journey where we find a supplement that truly resonates with our body
The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice
This is public information, but asking directly shows you are an informed consumer
The STEP 1 trial, published in the New England Journal of Medicine in 2021, showed that participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
Many of these studies are from large databases, which are powerful tools in elucidating patterns on a population level, but can also be misleading due to their immense statistical power
A lot of these people dont need to be on these medicines. This article first appeared in The Checkup, MIT Technology Reviews weekly biotech newsletter